| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 2.030 | 26.376 | 31.441 | 40.179 | 39.390 | 62.903 | 117.568 | 192.158 |
| Total Income - EUR | - | - | 2.030 | 26.376 | 31.441 | 40.179 | 39.390 | 62.903 | 117.568 | 192.259 |
| Total Expenses - EUR | - | - | 258 | 4.004 | 1.992 | 1.782 | 2.877 | 2.807 | 11.059 | 14.067 |
| Gross Profit/Loss - EUR | - | - | 1.773 | 22.372 | 29.449 | 38.397 | 36.514 | 60.095 | 106.509 | 178.192 |
| Net Profit/Loss - EUR | - | - | 1.712 | 21.581 | 28.506 | 37.278 | 35.509 | 58.644 | 105.357 | 172.539 |
| Employees | - | - | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 |
Check the financial reports for the company - Cardiosil Medical S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 0 | 504 | 1.263 | 798 | 1.100 | 212 | 0 | 592 |
| Current Assets | - | - | 2.059 | 21.625 | 27.697 | 38.923 | 71.832 | 61.179 | 106.109 | 173.964 |
| Inventories | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | 2.030 | 2.160 | 18.739 | 3.402 | 3.633 | 53.960 | 55.927 | 131.870 |
| Cash | - | - | 28 | 19.465 | 8.958 | 35.521 | 68.199 | 7.219 | 50.182 | 42.094 |
| Shareholders Funds | - | - | 1.755 | 21.632 | 28.556 | 37.328 | 72.009 | 58.693 | 105.405 | 172.587 |
| Social Capital | - | - | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | 303 | 497 | 404 | 393 | 291 | 2.642 | 703 | 1.968 |
| Income in Advance | - | - | 0 | 0 | 0 | 2.001 | 632 | 56 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Cardiosil Medical S.r.l.